Patents

Literature

Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Immunomodulatory Agent" patented technology

Filter

Efficacy Topic

Property

Owner

Technical Advancement

Application Domain

Technology Topic

Technology Field Word

Patent Country/Region

Patent Type

Patent Status

Application Year

Inventor

The immunomodulatory agents (IMiD), a group of orally bioavailable agents, derived from thalidomide are one of the important novel agents available for the treatment of MM. Currently, thalidomide and lenalidomide are commercially available, and pomalidomide has demonstrated early encouraging clinical activity.